B-type natriuretic peptide as a predictor of severity in admitted patients with acute exacerbation of COPD

被引:0
作者
Nasser K. Abdelnaby
Hassan A. Shabana
Waleed R. Arafat
机构
[1] Kasr El-Aini Hospital,Department of Chest Diseases
[2] Faculty of Medicine,Department of Chest Diseases
[3] Cairo University,undefined
[4] Faculty of Medicine,undefined
[5] Beni Suef University,undefined
来源
Egyptian Journal of Bronchology | 2019年 / 13卷
关键词
BNP; COPD; exacerbation; ICU; mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:289 / 297
页数:8
相关论文
共 90 条
[1]  
Rutten FH(2005)Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 26 1887-1894
[2]  
Cramer MJ(1991)Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 12 315-321
[3]  
Grobbee DE(2006)Heart failure and chronic obstructive pulmonary disease:an ignored combination Eur J Heart Fail 8 706-711
[4]  
Sachs AP(2001)B-type natriuretic peptide and its clinical utility in patients with heart failure MLO Med Lab Obs 33 10-14
[5]  
Kirkels JH(2000)Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease Clin Chim Acta 301 19-30
[6]  
Lammers JW(2004)Clinical significance of brain natriuretic peptide in primary pulmonary hypertension J Am Coll Cardiol 43 764-770
[7]  
Remes J(2008)Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD Chest 133 1088-1094
[8]  
Miettinen H(2011)Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD Thorax 66 764-768
[9]  
Reunanen A(2004)Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper Eur Respir J 23 932-946
[10]  
Pyörälä K(2008)Pulmonary hypertension in COPD. Eur Respir J 32 1371-1385